Tag: labile iron

Update on intravenous iron choices

This review examines the evolution of intravenous (IV) iron therapies, focusing on newer formulations such as ferumoxytol, ferric carboxymaltose, and iron isomaltoside. These agents possess more stable iron-carbohydrate complexes, allowing for higher single-dose administrations with reduced labile iron release, thereby minimizing infusion-related adverse events. Their enhanced safety profiles and dosing

Read More »

Iron Load Toxicity in Medicine: From Molecular and Cellular Aspects to Clinical Implications

This comprehensive review explores the multifaceted nature of iron toxicity, emphasizing the role of labile iron species in generating reactive oxygen species (ROS) that lead to oxidative stress, lipid peroxidation, and cellular damage. It discusses the molecular interactions of iron with dietary components, pharmaceuticals, and environmental toxins, highlighting their contribution

Read More »